Candel Therapeutics News

Candel Therapeutics | 8-K: Current report

Jun 28 08:41 ET

Candel Therapeutics | DEF 14A: Definitive information statements

May 30 16:37 ET

Candel Therapeutics | 8-K: Current report

May 30 16:20 ET

Candel Therapeutics | 8-K: Current report

May 23 17:08 ET

Candel Therapeutics | 8-K: Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

May 14 08:19 ET

Candel Therapeutics | 8-K: Current report

Apr 25 08:34 ET

Candel Therapeutics | 8-K: Current report

Apr 11 09:04 ET

Candel Therapeutics | 8-K: Current report

Apr 9 08:34 ET

Candel Therapeutics | 8-K: Current report

Apr 4 08:35 ET

Candel Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 28 08:19 ET

Candel Therapeutics | 8-K: Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights

Mar 28 07:49 ET

Candel Therapeutics | 8-K: Current report

Mar 6 08:03 ET

Candel Therapeutics | 8-K: Current report

Feb 13 07:49 ET

Candel Therapeutics | 8-K: Current report

Jan 12 00:00 ET

Candel Therapeutics | 8-K: Current report

Jan 3 00:00 ET

Candel Therapeutics | 8-K: Current report

Dec 14, 2023 18:33 ET

Candel Therapeutics | 8-K: Current report

Dec 12, 2023 08:30 ET

Candel Therapeutics | 8-K: Current report

Nov 28, 2023 09:00 ET

Candel Therapeutics | 8-K: Current report

Nov 21, 2023 17:00 ET

Candel Therapeutics | 8-K: Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Nov 9, 2023 08:16 ET